These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2518864)

  • 1. Single night-time doses of 40 mg famotidine or 800 mg cimetidine in the treatment of duodenal ulcer.
    Lee FI; Booth SN; Cochran KM; Crowe J; Dickinson RJ; Kennedy NP; Cottrell J; Mann SG
    Aliment Pharmacol Ther; 1989 Oct; 3(5):505-12. PubMed ID: 2518864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medium-dose antacids versus cimetidine in the short-term treatment of duodenal ulcer.
    Bianchi Porro G; Parente F; Lazzaroni M; Baroni S; Panza E
    J Clin Gastroenterol; 1986 Apr; 8(2):141-5. PubMed ID: 3745847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of smoking on healing rate of duodenal ulcer in response to cimetidine or high-dose antacid.
    Korman MG; Shaw RG; Hansky J; Schmidt GT; Stern AI
    Gastroenterology; 1981 Jun; 80(6):1451-3. PubMed ID: 7227770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent ulcer after successful treatment with cimetidine or antacid.
    Ippoliti A; Elashoff J; Valenzuela J; Cano R; Frankl H; Samloff M; Koretz R
    Gastroenterology; 1983 Oct; 85(4):875-80. PubMed ID: 6350097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antacid treatment of duodenal ulcer.
    Becker U; Lindorff K; Andersen C; Ranløv PJ
    Acta Med Scand; 1987; 221(1):95-101. PubMed ID: 3551508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antacid maintenance therapy in the prevention of duodenal ulcer relapse.
    Bardhan KD; Hunter JO; Miller JP; Thomson AB; Graham DY; Russell RI; Sontag S; Hines C; Martin T; Gaussen L
    Gut; 1988 Dec; 29(12):1748-54. PubMed ID: 3065157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, randomized, double-blind study comparing famotidine with cimetidine in the treatment of active duodenal ulcer disease.
    Rodrigo L; Viver J; Conchillo F; Barrio E; Forné M; Zozaya JM; Alvarez A; Dieguez P; Muñoz M; Panés J
    Digestion; 1989; 42(2):86-92. PubMed ID: 2570005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of cimetidine, famotidine, ranitidine, and mylanta in postoperative stress ulcers.
    Stuart RC; Hehir D
    Gastroenterology; 1992 Mar; 102(3):1091. PubMed ID: 1599547
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative efficacy of cimetidine, famotidine, ranitidine, and mylanta in postoperative stress ulcers. Gastric pH control and ulcer prevention in patients undergoing coronary artery bypass graft surgery.
    Lamothe PH; Rao E; Serra AJ; Castellano J; Woronick CL; McNicholas KW; Lemole GM
    Gastroenterology; 1991 Jun; 100(6):1515-20. PubMed ID: 2019357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Famotidine versus cimetidine in the treatment of acute duodenal ulcer. Double-blind, randomized clinical trial comparing nocturnal administration of 40 mg famotidine to 800 mg cimetidine.
    Hartmann H; Fölsch UR
    Digestion; 1988; 39(3):156-61. PubMed ID: 3061859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twice-a-day dosage of cimetidine in the short-term treatment of peptic ulcer.
    Eaves R; Korman MG
    Med J Aust; 1982 Nov; 2(11):518-20. PubMed ID: 7155043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre, randomized, double-blind study comparing nocte famotidine or ranitidine for the treatment of active duodenal ulceration.
    Alcalá Santaella R; Guardia J; Pajares J; Piqué J; Pita L; Alvárez E; Castellanos P; Guarner L; Ortiz J; Pesquera R
    Aliment Pharmacol Ther; 1989 Feb; 3(1):103-10. PubMed ID: 2491454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of a new antacid, synthetic hydrotalcite, in duodenal ulcer: clinical endoscopic study compared to cimetidine].
    Piai G; Cimino L; D'Argenio G; Mazzacca G
    Clin Ter; 1980 Nov; 95(3):269-77. PubMed ID: 7214842
    [No Abstract]   [Full Text] [Related]  

  • 14. Morning versus evening dose: a comparison of three H2-receptor blockers in duodenal ulcer healing.
    Khasawneh SM; Affarah HB
    Am J Gastroenterol; 1992 Sep; 87(9):1180-2. PubMed ID: 1519576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of duodenal ulcers with antacids].
    Ottenjann R; Kunert H; Weingart J; Höchter W
    Z Gastroenterol; 1983 Mar; 21 Suppl():74-80. PubMed ID: 6858412
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative study of cimetidine and Mylanta II in the 6-week treatment of gastric ulcer.
    Sherbaniuk RW; Wensel RH; Bailey RJ; Kirdeikis P; Fisher D; Thomson AB
    J Clin Gastroenterol; 1985 Jun; 7(3):211-5. PubMed ID: 3894494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse rates of duodenal ulcer healed with concentrated antacid or cimetidine.
    Hentschel E; Schuetze K; Dufek W
    Hepatogastroenterology; 1984 Dec; 31(6):266-8. PubMed ID: 6519637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of active prepyloric and duodenal ulcers with antacid/anticholinergic, cimetidine and placebo.
    Gotthard R; Ström M; Bodemar G; Walan A
    Scand J Gastroenterol Suppl; 1982; 75():86-96. PubMed ID: 6755656
    [No Abstract]   [Full Text] [Related]  

  • 19. Cimetidine, 800 mg at night, in the treatment of duodenal ulcers.
    Kildebo S; Aronsen O; Bernersen B; Breckan R; Gjellestad A; Johnsen K; Sandvik A
    Scand J Gastroenterol; 1985 Nov; 20(9):1147-50. PubMed ID: 3911367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The efficacy of using letsedil for treating patients with digestive organ diseases].
    Degtiareva II; Semeunović S; Petrović S; Gaĭsenko AV; Kharchenko NV; Egorova IT
    Klin Med (Mosk); 1996; 74(2):26-8. PubMed ID: 8772096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.